Aerovate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AVTE and buy or sell other stocks, ETFs, and their options commission-free!

About AVTE

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. 

CEO
Tom Frohlich, MBA
CEOTom Frohlich, MBA
Employees
30
Employees30
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
30
Employees30

AVTE Key Statistics

Market cap
8.12M
Market cap8.12M
Price-Earnings ratio
-0.12
Price-Earnings ratio-0.12
Dividend yield
—
Dividend yield—
Average volume
217.12K
Average volume217.12K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$884.98
52 Week high$884.98
52 Week low
$7.05
52 Week low$7.05

People also own

Based on the portfolios of people who own AVTE. This list is generated using Robinhood data, and it’s not a recommendation.
FuelCell Energy
Ocugen, Inc
Plug Power
Lucid Group
SNDL
Mullen Automotive
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.